Table 1

Loss-of-function studies on major BM components

GenesKnockout/mutationCre promoterKnockout phenotypeReferences
Collagen IV
 Collagen 4A1/2Global knockoutBM structural deficiencies and embryonic lethality (E10.5–E11.5)39
 Collagen 4A1Lacking exon 41 in both allelesEmbryonic lethality45
 Collagen 4A1Lacking exon 41 in one alleleIntracerebral haemorrhage and porencephaly40 41
 Collagen 4A1Conditional knockoutRosa26-CreER, Tie2-Cre, Pdgfrb-Cre, Gfap-CreIntracerebral haemorrhage and porencephaly with different severity42
 Collagen 4A1/2Missense mutationsVascular defects and brain malformations43 44
 Collagen 4A2Missense mutationsIntracerebral haemorrhage45
Laminin
 Laminin α2Global knockoutBBB disruption58
 Laminin α4Global knockoutHaemorrhage during embryonic/neonatal stage68
 Laminin α5Global knockoutEmbryonic lethality (~E17) and defects in neural tube closure and neural crest cell migration52–54
Conditional knockoutTie2-Cre
(endothelium)
No gross CNS abnormalities under homeostatic conditions70 71
 Laminin β1Global knockoutEmbryonic lethality (E5.5–E6.5)55
 Laminin γ1Global knockoutEmbryonic lethality (E5.5–E6.5)55–57
Conditional knockoutNestin-Cre (neural progenitors)BBB breakdown and intracerebral haemorrhage1 87
Conditional knockoutPdgrfb-Cre (mural cells)Hydrocephalus and BBB breakdown51
Nidogen
 Nidogen-1Global knockoutMild BM alteration in brain capillaries72–74
 Nidogen-2Global knockoutNo effect on BM formation75
 Nidogen-1 and nidogen-2Global knockoutBM defect and perinatal lethality77–79
Perlecan
 PerlecanGlobal knockoutEmbryonic lethality (E10–E12)84–86
  • BBB, blood–brain barrier; BM, basement membrane; CNS, central nervous system.